This website sets cookies which are used to offer a personalized experience on our website, generate statistics, and realize advertising or social network tracking. Find out more about our Privacy & Cookie policy and how to manage them on your browser. You can change your cookie settings at any time.

Includes the Inaugural North American Viral Hepatitis Elimination Summit

Program

VIRTUAL PLATFORM ACCESS

Click Here to access the CLM Virtual Platform.

Reach out to clm_reg@mci-group.com for any assistance with logging in.

*Subject to Change

Times are in Eastern Daylight Time (EDT)

Tuesday, May 4, 2021

  • 09:30 10:00

    BREAK | VISIT THE VIRTUAL EXHIBITION

  • 10:00 16:15

    North American Viral Hepatitis Elimination Summit

  • 10:00 11:00

    Concurrent Sessions

    CLM Symposium 1 – Basic Science and Translational Research - Novel Approaches to Targeting Chronic Liver Disease and Liver Injury
    Moderator: Chris Rose

    10:00 - 10:15 | Clinical Evidence on Targeting the Gut Microbiome in Chronic Liver Disease | Johane Allard, Medical Expert, Scholar

    10:15 - 10:30 | Hepatic stellate in liver disease and cancer | Robert Schwabe, Medical Expert, Scholar

    10:30 - 10:45 | Single Domain Nanobodies Targeting Viral Infection | Trushar Patel, Medical Expert

    10:45 - 11:00 | Discussion

    CLM Symposium 2 – Special Topics in Hepatology
    Moderator: Kelly Burak

    10:00 - 10:15 | Approaches to Complications in PSC Management | Angela Cheung, Medical Expert

    10:15 - 10:30 | HCC Management in 2021 (Include Post-Transplant Surveillance for HCC) | Alex Aspinall, Medical Expert

    10:30 - 10:45 | Acute-On – Chronic Liver Failure in the Era of COVID-19 | Constantine Karvellas, Medical Expert, Health Advocate, Leader

    10:45 - 11:00 | Discussion

  • 11:00 11:50

    How COVID has Impacted Viral Hepatitis and the Elimination Agenda

    This session was co-developed with Gilead and was planned to achieve scientific integrity, objectivity and balance.

    Moderator: John Ward

    11:00 - 11:20 | Effects of COVID-19 on the Cascade of Care | Naveed Janjua, Health Advocate, Leader

    11:20 - 11:40 | Lessons Learned from COVID that Could Enhance Viral Hepatitis Elimination | Betsy Verna, Communicator, Leader, Health Advocate

    11:40 - 11:50 | Q&A

  • 11:00 11:30

    HDV Cure

    Moderator: Scott Fung

    11:00 - 11:20 | HDV Cure: How close are we and what tools do we need? | Jeffrey Glenn, Medical Expert, Scholar

    11:20 - 11:30 | Discussion

  • 11:30 13:00

    Strategies for HBV Cure

    Moderator: Timothy Block

    11:30 - 11:50 | The Antiviral Approach | Anna Lok, Medical Expert, Communicator

    11:50 - 12:10 | The Immunological Approach | Barbara Rehermann, Medical Expert, Communicator

    12:10 - 12:30 | HCC After Cure of HCV or Suppression of HBV | Emmanuel Thomas, Medical Expert, Scholar

    12:30 - 13:00 | Panel Discussion

  • 11:50 13:00

    Opportunities from COVID to Enhance Elimination

    Moderator: Jordan Feld, Health Advocate, Medical Expert

    11:50 - 12:10 | Leveraging COVID Testing to Enhance HBV and HCV Screening: Opportunities for Progress Toward Elimination | Mel Krajden, Health Advocate, Medical Expert, Leader

    12:10 - 12:30 | COVID-19 in Patients with Liver Disease and Management of Viral Hepatitis in the COVID Era | Oren Fix, Leader, Health Advocate, Medical Expert

    12:30 - 13:00 | Panel Discussion Focused on Catch-up from COVID to Get Back on Track | Norah Terrault

  • 13:00 13:30

    BREAK | A CASE BASED ROUND TABLE DISCUSSION

    The MDT Approach to HCC Management | Howie Lim & Dave Liu

    This is an unaccredited other learning activity, with content developed by the speaker, and was made possible with the support of Eisai.

  • 13:00 13:30

    BREAK | VISIT THE VIRTUAL EXHIBITION

  • 13:30 14:30

    Oral Presentations ‑ Panel 2

    Moderator: Joyce Wilson

    13:30 - 13:40 | Cd8+ T Cell Hyperfunction In A Murine Model Of Liver Fibrosis | Jood Madani

    13:40 - 13:50 | Enriched Plasma Cell Transcriptomic Signatures And Humoral Responses During Hcv Reinfection And Clearance | Sabrina Mazouz

    13:50 - 14:00 | The Impact Of Small Rna Binding On Hepatitis C Virus Replication Via Structural Changes Within The 5’ Untranslated Region | Michael Palmer

    14:00 - 14:10 | Higher Seroprotection Rates (Sprs) And Higher Anti-Hbs Concentrations In Adults Age 18+ Achieved With 3-Antigen Hepatitis B Vaccine (3A-Hbv) Compared To 1-Antigen Hepatitis B Vaccine (1A-Hbv): Results From The Pivotal, Double-Blind, Randomized Phase 3 Study (Protect) | Francisco Diaz-Mitoma

    14:10 - 14:30 | Q&A

  • 13:30 14:30

    CAHN Session

    Nurse-Led Models of Care
    Moderator: Leo Yamamoto


    13:30 - 13:50 | HCV Micro Elimination at the Calgary Drop-In Center: an interdisciplinary approach to screening and treatment | Kate Newcombe

    13:50 - 14:10 | Culturally Relevant Perspectives Informing Indigenous Liver Health Awareness | Kate Dunn

    14:10 - 14:30 | Cirrhosis Care Alberta - a QI project | Michelle Carbonneau

  • 14:30 15:30

    CAHN Session

    Case Studies In Liver Disease
    Moderator: Leeya Brind’Amour


    14:30 - 14:45 | HCV treatment dilemma | Liza Abraham

    14:45 - 15:00 | Serious Illness Conversations in Advanced Liver Disease | Jacqui Pinto

    15:00 - 15:15 | HCV reinfection | Pam Ford

    15:15 - 15:30 | Q&A

  • 14:30 15:00

    CanHepC Awards Ceremony

    Presented by: Norma Choucha, Chris Richardson, Naglaa Shoukry, & CanHepC trainees

  • 15:00 15:30

    Elimination Summit Next Steps and Closing Remarks

    15:00 - 15:15 | An elimination call from Community - Elimination Progress Report by Action Hepatitis Canada | Sofia Bartlett & Jennifer van Gennip

    15:15 - 15:20 | From Blueprint to Roadmap | Jordan Feld

    15:20 - 15:25 | Hepatitis Elimination Profiles US & Canada & Closing Remarks | John Ward

    15:25 - 15:30 | I Never Had No Nobel Dreams | Harvey Alter (Poem, World Premiere)

  • 15:30 17:00

    CAHN AGM

  • 15:30 16:30

    CASL AGM

  • 15:30 16:30

    VISIT THE VIRTUAL Exhibition

  • 15:30 16:15

    Poster Tours

    Poster Tour 3

    Poster Tour 4